BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
| Website | http://www.bbbiotech.ch |
| Ticker | BIO |
| Revenue | $313 million |
| Employees | View employees |
| Founded | 1993 |
| Address | 16 Seestrasse, Kuesnacht, Zurich 8700, CH |
| Phone | +41 52 624 08 45 |
| Fax | +41 44 267 67 01 |
| Technologies |
JavaScript
,
HTML
,
PHP
+17 more
(view full list)
|
| Industry | Business Services General, Alternative Medicine, Other Capital Markets/Institutions, Business Services, Health Care, Biotechnology, Science and Engineering, Pharmaceutical, Professional Services |
| Web Rank | 1 Million |
| Keywords | Bbbiotech, Bb Biotech, Aktie Bb Biotech, Bellevue Biotech Fund, Bb Biotech 2016 |
| Competitors | Thermo Fisher Scientific, Moderna Therapeutics, Amgen, Roche, Regeneron, Bristol Myers Squibb, Gilead Sciences, Genentech, Biogen, Vertex Pharmaceuticals +47 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies |
Looking for a particular BB Biotech AG employee's phone or email?
BB Biotech AG Questions
The BB Biotech AG annual revenue was $313 million in 2026.
BB Biotech AG is based in Kuesnacht, Zurich.
The NAICS codes for BB Biotech AG are [54171, 54, 541, 5417, 541713].
The SIC codes for BB Biotech AG are [87, 873].
